TABLE 1.
Strain or plasmid | Descriptiona | Source or reference |
---|---|---|
S. flexneri strains | ||
2457T | Serotype 2a | 82 |
AWY3 | 2457T virB::Tn5 Knr | 16 |
BS103 | 2457T cured of the virulence plasmid | 83 |
Plasmids | ||
pJNS04 | pBAD-virB; Ampr | This study |
pJNS10 | pBAD-gfp-12AA linker-virB; Ampr | This study |
pJNS12 | pBAD-gfp-virB; Ampr | This study |
pJNS13 | pBAD-gfp-virB K152E; Ampr | This study |
pJNS18 | pBAD-gfp-virB K152E/R167E; Ampr | This study |
pJNS22 | pACYC177 carrying 25-bp VirB-binding site derived from pBT-PicsP (36); Cmr | This study |
pJNS24 | pACYC177 without 25-bp VirB-binding site derived from pBT-empty (36); Cmr | This study |
pJH66 | pBAD-linker-gfp; Ampr | 79 |
pBAD/His A | pBR322-derived expression vector allowing regulated and dose-dependent recombinant protein expression; Ampr | Invitrogen |
pAFW04 | pACYC184-PicsP-lacZ; Cmr | 17 |
pHJW20 | WT PicsP fused to lacZ; Cmr | 35 |
pMIC18 | pHJW20 with a mutated VirB-binding site; Cmr | 35 |
pJAI28 | WT PospD1 fused to lacZ; Cmr | 18 |
pJAI36 | pJAI28 with mutated VirB-binding sites; Cmr | 18 |
pATM324 | pBAD18-virB; Ampr | 67 |
Knr, kanamycin resistance; Ampr, ampicillin resistance; Cmr, chloramphenicol resistance.